attractive. An advantage of this approach is the ability to achieve a locally high concentration of the drug while limiting unwanted systemic effects by dilution into tissue fluids and blood. A particularly exciting enhancement of local drug delivery involves the use of drug formulations designed for sustaining release of the desired agents. By controlling the release of drug in a local tissue environment, it is possible to match the properties of the medication to both the spatial and temporal features of a disease process. In the case of postangioplasty restenosis, a specific sequence of events characterizes the repair process after mechanical injury of an artery: migration of cells to the injury site and proliferation is followed by synthesis of extracellular matrix.' These processes, any of which could be a target for drug therapy, occur over several weeks in a double-injury Microspheres were produced by a modified solvent evaporation process.6 Briefly, the process involves emulsification followed by solvent evaporation. The polymers chosen for pilot drug release studies included polylactides as well as several lactide/glycolide copolymers (Birmingham Polymers, Inc). Cellular studies were performed with particles incorporating a copolymer with a lactide/glycolide ratio of 50:50 and an inherent viscosity of 0.7 dL/g (hexafluoroisopropanol, 30'C).
The CA was derived from colchicine by substitution of a bulky hydrophobic side chain on the colchicine heterocyclic ring. After incorporation of the CA into the polymer matrix, the drug-containing microspheres were filtered, washed extensively with sterile water, and dried.
Determination of Total Drug Loading and Release Kinetics
The total content of the CA within the microspheres was determined spectrophotometrically by ultraviolet absorption of an appropriate weight of microspheres dissolved in chloroform, using the absorbance maximum of CA (molar absorptivity, 2.11 x 10 at 386 nm). Such determinations were repeated in triplicate. The release characteristics were determined in a physiological saline solution adjusted to pH 7.4, with 1% Tween 80 (Sigma Chemical Co). Particles were suspended at concentrations ranging from 0.01 to 0.4 mg/mL and sonicated, monitoring the dispersion process with microscopic inspection.
Aliquots of this homogeneous suspension were then divided into multiple 1.5-mL tubes, which were shaken at 370C and 200 rpm until each time point was to be taken. Individual tubes were used singly for time point determinations, which were performed by determination of the supernatant absorbance at the maximum as above after centrifugation at 14 000g.
Physical Characterization of Microspheres
Microsphere morphology was examined with a Phillips 500 scanning electron microscope operated at 25 kV with an 8-nm spot size after sputter-coating with gold/palladium alloy. Size distribution was determined with a Microtrac FRA particle analyzer (Leeds and Northrup added to a concentration of 2 j.Ci/mL at 42 hours after drug exposure, and cells were harvested after 6 hours of incorporation. At the end of the incubation, cells were released from the wells, incorporated precursor was removed by washing with distilled water, and cell residues were collected on glass mesh filters by an automated cell harvester. Radioactivity was measured by liquid scintillation spectroscopy. Some experiments also used polycarbonate filter insets (Costar) immersed in the plate wells above the cells to determine the effect of loss of direct cell/bead contact on the results.
Results

Physical Properties and Release Kinetics of Microspheres
Multiple sets of microspheres were produced with a variety of polymer-to-drug ratios and reaction conditions until an optimal set of conditions was determined that allowed the reproducible formation of both colchicine-and CA-containing particles fulfilling three criteria: (1) average diameter range from 5 to 10 ,um; (2) total drug load of 15% to 17% (wt/wt); and (3) release of drug content over more than 3 to 4 weeks in sink conditions in vitro.9 Three consecutive reactions then yielded particles with these characteristics. Scanning electron microscopy of a representative batch of drugloaded particles is shown in Fig 1A. These particles are spherical, with approximately 80% of total mass contributed by particles ranging in diameter from 3 to 8 ,um, as shown in the histogram (Fig 1B) .
During passage of several lots of particles through porous infusion catheters (Advanced Cardiovascular Systems, Inc), flow was not routinely seen to fall by more than 20% over the increasing concentration range tested (105 to 10' particles/mL) under an infusion pressure of 6 atm; pore occlusion was not noted in any of these studies (data not shown).
The total drug loads for three particle lots containing CA were 16%, 16%, and 17% (wt/wt). Release of the CA from these particles in vitro over the course of 1 month featured an initial burst of release of approximately 4% of the total drug load. Subsequent determinations of drug levels showed a release of 16% of the incorporated drug over the ensuing month with nearly zero-order kinetics (Fig 1C) (Fig 2A) . In contrast, control microspheres composed only of polymer with no incorporated active drug demonstrated no observable toxicity to BASMCs and <40% inhibition of thymidine incorporation even in suspensions containing up to 0.5 g% particles. The EC50 values observed for both loaded microparticles were very similar in experiments using serum-stimulated cells (data not shown). Cell counting was used to evaluate the effects on proliferation of extended exposure to the active microspheres. This revealed substantial stasis of growth at subconfluent cell densities at particle concentrations as low as 0.0001% (wt/wt) ( Fig  2D) . Cell viability as assessed by trypan blue staining was approximately 80% after 7 days of incubation with microparticles at this concentration. There was no apparent effect on cell growth after 7 days of incubation with control (microparticles at any concentration up to 0.001%); cell viability in these experiments was approximately 95%.
Morphological changes suggesting microtubule depolymerization were observed after both CA particle treatment (Fig 2B) and colchicine-particle treatment (not shown) at similar EC50 values, whereas cellular morphology appeared essentially unperturbed in the presence of polymer-only particles (Fig 2C) . Fig 2B is taken under combination Hoffman modulation and epifluorescence excitation in the range of 480 nm with emission detection in the range of 510 nm. This additionally reveals the fluorescence of the CA incorporated within the polymeric matrix and shows it to have a microaggregated distribution, creating a substructure in the polymeric particles. Particles without drug did not demonstrate epifluorescence (not shown).
Discussion
Since the report by Wolinsky and Thung4 describing the porous balloon catheter, numerous reports using such catheters to deliver medications into the vascular wall have appeared in the literature.10 Despite the initial promise of this balloon, it has become apparent that successful delivery into the vascular wall is not synonymous with retention in the wall. Studies with several agents have demonstrated drug disappearance from the arterial wall within several hours to several days.4'11'12 Given the time course of the postangioplasty response as described above, this may explain the lack of any measurable advantage of administration of heparin, methotrexate, or colchicine via porous balloon application in animal models of angioplasty restenoSiS.11-13 The . . --these particles is consistent with results found in studies of larger microparticles demonstrating slowest release rates for compounds with low hydrophilicity. 21"26,27 Given microparticles with these characteristics, the local drug concentration and thus effectiveness in an in vivo setting will be dependent on a balance between the rate of drug release and the parameters of distribution from the arterial wall after release. Local drug distribution will in turn be determined by intramural diffusion and convection. Convective fluid flux through an arterial wall increases with endothelial denudation28 or even hypercholesterolemia. 29 The presence of extensive atherosclerosis, which also leads to considerable plaque neovascularization,30 may substantially change the dynamics of drug washout as well. For these reasons, extension of the studies in cell culture into well-described animal models will be critical as the next step in assessing the feasibility of local microparticle-based therapeutics of the vascular wall.
In conclusion, biodegradable microspheres have been fashioned that release a CA and inhibit DNA synthesis in smooth muscle cells. Such particles, containing agents such as these antimitotics, heparin, or possibly antisense oligonucleotides, are candidates for local delivery at sites of arterial injury to decrease restenosis.
